All countries around the world unite again to discuss issues about the world drug problem in the United Nations General Assembly Special Session on Drugs in New York City, USA from 19-21 April 2016.

Dangerous Drugs Board (DDB) Chairman Sec. Felipe L. Rojas Jr., together with Permanent Board Member Usec. Edgar C. Galvante, and other officials from the Board’s member agencies such as the Department of Justice (DOJ), Department of Health (DOH), and the Philippine Drug Enforcement Agency (PDEA) form part of the Philippine delegation to the forum where they will also report on the country’s drug prevention and control accomplishments and plans to address new issues and challenges on the anti-drug fight.

Among the most pressing concerns that the assembly will discuss are the development and implementation of strategies anchored on human rights-based approaches and identification of effective responses to social and health impacts of drugs.

In line with this, the Philippine delegation will report on the institutionalization of the country’s National Anti-Drug Plan of Action or NADPA, a comprehensive plan that balances supply and demand reduction efforts, strengthening preventive education programs as well as treatment and rehabilitation services. It also promotes alternative development, elicits social response and facilitates regional and international cooperation.

UN convenes a special session on the world drug problem to review progress in the implementation of the Political Declaration and Plan of Action on International Cooperation towards an integrated and balanced strategy to counter the world drug problem. It is also a way of assessing the achievements and challenges in countering the world drug problem, within the framework of the three (3) international drug control conventions and other relevant United Nations instruments.